Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Completed Phase 2 Trials for Tipifarnib (DB04960)

IndicationStatusPhase
DBCOND0028534 (Adult Acute Minimally Differentiated Myeloid Leukemia (M0))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00027872Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaTreatment
NCT00093418S0432 Tipifarnib in Treating Older Patients With Acute Myeloid LeukemiaTreatment
NCT00602771Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid LeukemiaTreatment